Inhibition of LAT1, which has been reported to show tumor-dominant expression and an association with prognosis, is expected to suppress tumor progression by reducing tumor-specific amino acid uptake, leading to starvation, with minimal effect on normal cells. Here, SLC7A5 is linked to neoplasm.